Simvastatin Attenuates Doxorubicin-Induced Inflammation in Human Cardiomyocytes
<b>Background/Objectives</b>: Clinical application of Doxorubicin (Doxo) is limited by cardiotoxicity, a process strongly associated with an interplay between oxidative stress and inflammatory signaling, particularly Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation a...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2026-05-01
|
| Sarja: | Biomedicines |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2227-9059/14/5/1071 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|